Maryland Mandates Mammogram Calcification Reporting

A new law requires that patients be informed if their routine mammograms reveal signs of breast arterial calcification.

Updated on Oct. 15, 2026 in Heart Disease

Maryland Mandates Mammogram Calcification Reporting

Live Poll

Do you believe mandatory medical test result disclosures help patients make better health decisions?

Maryland has officially enacted legislation requiring imaging centers to notify patients when breast arterial calcification is detected during routine screenings. This mandate ensures that women are alerted to potential cardiovascular risks identified during breast cancer screenings.

Why it matters

Breast arterial calcification can serve as a key indicator of underlying heart disease, which is the leading cause of death for women. This policy aims to facilitate earlier cardiovascular intervention for patients before a serious cardiac event occurs.

Patients typically begin receiving annual mammograms at age 40. The notification process utilizes FDA-approved AI technology to identify white lines in imagery and requires no extra imaging or additional costs for the patient.

The players

MedChi

The Maryland State Medical Society is a professional association that supports the notification requirement as part of its healthcare advocacy.

American College of Obstetricians and Gynecologists

This professional organization of physicians specializes in the health care of women and supports the state's initiative for arterial notification.

The details

Imaging centers across the state have implemented staff training and developed informational handouts to assist doctors in communicating these findings. The new requirement applies to all screening results performed in the state of Maryland.

October 2026: The new Maryland law regarding mammogram notifications went into effect.

The Big Picture

The Maryland breast arterial calcification notification law marks a shift in how diagnostic imaging is used for broader health screening. This legislation follows a pattern of utilizing existing preventive screenings to capture secondary health data without adding patient costs.

Women receiving mammograms in Maryland will now be proactively informed if their results show signs of arterial calcification. This information allows patients to discuss their cardiovascular risk profile with their primary care provider during routine visits.

The takeaway

Patients who receive a notification should treat the finding as a sign to discuss cardiovascular health with their doctor. Early identification of these calcifications provides a window to manage heart disease risks through lifestyle changes or medical guidance.